Nuveen, LLC Amneal Pharmaceuticals, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 2,336,628 shares of AMRX stock, worth $17.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,336,628Holding current value
$17.6 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding AMRX
# of Institutions
217Shares Held
128MCall Options Held
362KPut Options Held
131K-
Vanguard Group Inc Valley Forge, PA15.8MShares$119 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$93 Million2.69% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$85.1 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$80.8 Million1.4% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il8.98MShares$67.7 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.14B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...